Moreover, transient COX-2 inhibitor treatment significantly improved the response to phenobarbital in a chronic rodent model of drug-resistant epilepsy suggesting beneficial effects of COX-2 inhibition (5). The gene discussed is PTGS2; the disease is epilepsy.